Abstract
Arrhythmogenic right-ventricular dysplasia/cardiomyopathy (ARVD/C) is a disease of heart muscle that is characterized histologically by fibrofatty replacement of the RV myocardium and clinically by the development of symptomatic ventricular arrhythmias. Patients with ARVD/C frequently receive implantable cardioverter-defibrillators (ICDs). In a 23-center study (22 in Italy), funded partly by an ICD manufacturer, researchers followed 132 patients (mean age, 40) who met European Society of Cardiology criteria …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
